U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.202T>G (p.Cys68Gly) AND Familial hypercholesterolemia

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Dec 5, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001066278.10

Allele description [Variation Report for NM_000527.5(LDLR):c.202T>G (p.Cys68Gly)]

NM_000527.5(LDLR):c.202T>G (p.Cys68Gly)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.202T>G (p.Cys68Gly)
HGVS:
  • NC_000019.10:g.11102675T>G
  • NG_009060.1:g.18295T>G
  • NM_000527.5:c.202T>GMANE SELECT
  • NM_001195798.2:c.202T>G
  • NM_001195799.2:c.190+2330T>G
  • NM_001195800.2:c.202T>G
  • NM_001195803.2:c.202T>G
  • NP_000518.1:p.Cys68Gly
  • NP_001182727.1:p.Cys68Gly
  • NP_001182729.1:p.Cys68Gly
  • NP_001182732.1:p.Cys68Gly
  • LRG_274t1:c.202T>G
  • LRG_274:g.18295T>G
  • NC_000019.9:g.11213351T>G
  • NM_000527.4:c.202T>G
Protein change:
C68G
Links:
dbSNP: rs1057519652
NCBI 1000 Genomes Browser:
rs1057519652
Molecular consequence:
  • NM_001195799.2:c.190+2330T>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000527.5:c.202T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.202T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.202T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.202T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001231285Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Dec 28, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV004358470Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Dec 5, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Disulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain.

Bieri S, Djordjevic JT, Daly NL, Smith R, Kroon PA.

Biochemistry. 1995 Oct 10;34(40):13059-65.

PubMed [citation]
PMID:
7548065

Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.

Daly NL, Scanlon MJ, Djordjevic JT, Kroon PA, Smith R.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6334-8.

PubMed [citation]
PMID:
7603991
PMCID:
PMC41512
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001231285.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant affects a cysteine residue located within an LDLRA or epidermal-growth-factor (EGF)-like domains of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 7548065, 7603991, 7979249). In addition, missense substitutions within the LDLRA and EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with LDLR-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with glycine at codon 68 of the LDLR protein (p.Cys68Gly). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and glycine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV004358470.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This missense variant (also known as p.Cys47Gly in the mature protein) replaces cysteine with glycine at codon 68 of the LDLR protein. This variant alters a conserved cysteine residue that is critical for proper protein folding and function (PMID: 2088165, 6091915, 15952897). Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with LDLR-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024